In combination of these characteristics, R848@M2pep-MPsAFP efficiently boost anti-PD-1 therapy in HCC, generating antitumor immune memory and inducing stronger stem-like CD8+ T cell proliferation and differentiation to achieve a long-term immune surveillance (Fig. 1b). This evidence concerns the gene CD8A and hepatocellular carcinoma.